Cocrystal Pharma COCP
NASDAQ COCP
$1.15 -0.02 (-1.71%)
At close: Aug 21, 2026 · 4:00 PM EDT

Cocrystal Pharma (COCP) Non Operating Investment Income (2014 - 2015)

Cocrystal Pharma (COCP) posted Non Operating Investment Income of $744000.0 for Q2 2015, up 175.92% sequentially from -$980000.0 in Q1 2015, and down 77.82% YoY from $3.4 million in Q2 2014.

Cocrystal Pharma (COCP) Non Operating Investment Income (2014 - 2015) Analysis & Trends

Cocrystal Pharma has reported Non Operating Investment Income for 2 years, with the latest figure at $744000.0 in Q2 2015.

  • Quarterly Non Operating Investment Income fell 77.82% year-over-year to $744000.0 in Q2 2015, while the trailing twelve-month figure through Jun 2015 was -$704000.0 (changed N/A YoY) and the FY2014 annual result came in at $1.4 million, changed N/A from the prior year.
  • Non Operating Investment Income advanced to $744000.0 in Q2 2015 per COCP's latest filing, from -$980000.0 in the prior quarter.
  • Over five years, Non Operating Investment Income peaked at $3.4 million in Q2 2014 and troughed at -$980000.0 in Q1 2015.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Investment Income (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Cocrystal Pharma 15.65 Mn 13.33 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2015 744,000.00
Jun 30, 2015 744,000.00
Mar 31, 2015 -980,000.00
Mar 31, 2015 -980,000.00
Dec 31, 2014 -876,000.00
Dec 31, 2014 -876,000.00
Sep 30, 2014 408,000.00
Sep 30, 2014 408,000.00
Jun 30, 2014 3.35 Mn
Jun 30, 2014 3.35 Mn